{"id":"W4308523453","doi":"10.1158/1078-0432.ccr-22-2191","title":"Triple-Negative PAM50 Non-Basal Breast Cancer Subtype Predicts Benefit from Extended Adjuvant Capecitabine","year":2022,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Capecitabine; Internal medicine; Oncology; Medicine; Breast cancer; Triple-negative breast cancer; Basal (medicine); Cancer; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021141,0.0002605511,0.0005477212,0.0001886922,0.0001130573,0.0003943118,0.0002223754,0.0002941447,0.002299312],"category_scores_gemma":[0.003259687,0.0001294654,0.0006346068,0.0001718291,0.0002280666,0.0002406557,0.0002119436,0.0005099596,0.0001773431],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002392521,"about_ca_system_score_gemma":0.0002598359,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005296357,"about_ca_topic_score_gemma":0.001009466,"domain_scores_codex":[0.9995105,0.0002354015,0.00003239344,0.0001039724,0.00007185567,0.00004582206],"domain_scores_gemma":[0.9978022,0.001293403,0.0004918089,0.0001606226,0.00004836555,0.0002035504],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04730795,0.0002064574,0.9096105,0.0001597483,0.001422548,0.00008993252,0.00003634545,0.001329996,0.00658127,0.00009680591,0.0003058946,0.03285255],"study_design_scores_gemma":[0.0008732142,0.004155311,0.9853357,0.00003504334,0.001493429,0.0003953192,0.00004821001,0.004982205,0.001666277,0.0002199718,0.0007857627,0.000009597434],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972466,0.001332128,0.0002998954,0.00009638773,0.00001378752,0.00002180636,0.0001846865,0.000007555354,0.0007972096],"genre_scores_gemma":[0.999485,0.0001118096,0.0001224299,0.00003259646,0.00001412518,0.000007822495,0.0001176478,0.00000141283,0.0001070234],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002299312,"threshold_uncertainty_score":0.01118058,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07225856200408001,"score_gpt":0.4286964893067917,"score_spread":0.3564379273027116,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}